Attached files

EXHIBIT 10.1

                   AMENDMENT TO ASSET PURCHASE AGREEMENT DATED
                                 AUGUST 23, 2011


This Amendment made this 29th day of August, 2012.

                  Peptide Technologies Inc
                  601 Union Square
                  42nd Floor
                  Seattle Washington 98101


WHEREAS the Purchase  price of the Asset was reduced from  75,000,000  shares to
45,000,000 shares, and,

         NOTE: An Amendment to the Asset Purchase  Agreement dated December 2011
         reduced  the  purchase  price of the Asset  from  75,000,000  shares to
         45,000,000 shares. As a result thirty million  (30,000,000) shares were
         returned to treasury.


WHEREAS the Assets that were purchased were set aside and new formulations  were
developed by the Company; and,

WHEREAS the Finders Fees as incorporated in the Agreement are no longer valid.

NOW THEREFORE the  Directors  and Officers of the Company have  determined  that
SECTION 11.13 of the Asset Purchase Agreement shall be amended.

SECTION to be amended reads as follows

     SECTION 11.13Finders/Founders
          Richard E.  Fortescue  and Deborah E.  Fortescue-Merrin  shall each be
     issued  Fifteen  Million  (15,000,000)  shares  from the  75,000,000  share
     consideration    hereinabove   set   forth   for   services   rendered   as
     Finders/Founders.

The undersigned have agreed to the following Amendment:

SECTION as amended shall read as follows

     SECTION 11.13 Founders
          Richard E. Fortescue and Deborah Fortescue-Merrin shall each be issued
     One  Million  (1,000,000)  shares  for a total of Two  Million  (2,000,000)
     shares from the 45,000,000  share  consideration  hereinabove set forth for
     Founders  and  Officers.  Scott  McKinley  will receive the  difference  of
     Thirteen  Million  (13,000,000)  shares for a total of Forty Three  Million
     (43,000,000) shares.







Counterparts:

This  Amendment may be executed in  counterparts  (including  e-mail  attachment
(PDF) or  facsimile).  Each such  counterpart  so executed and delivered will be
considered  to  be  an  original  and  such  counterparts  taken  together  will
constitute one and the same document.



WHEREAS ALL DIRECTORS AND OFFICERS HEREBY AGREE TO ALL HEREIN
This  amendment  to the  agreement  is governed by the Law of British  Columbia,
Canada


Peptide Technologies Inc.




Per                                        Per
    ---------------------------------          --------------------------------
    Deborah Fortescue-Merrin                   Scott McKinley


Per
    ---------------------------------
    Richard Fortescu